Feedback welcome
GLUCOSE,FASTING 79 65-99 mg/dL
SODIUM 142 135-146 mmol/L
POTASSIUM 3.9 3.5-5.3 mmol/L
CHLORIDE 102 98-110 mmol/L
CARBON DIOXIDE 31 21-33 mmol/L
UREA NITROGEN 12 7-25 mg/dL
CREATININE 1.07 0.60-1.35 mg/dL
CALCIUM 9.7 8.6-10.3 mg/dL
PROTEIN,TOTAL 7.0 6.2-8.3 g/dL
ALBUMIN 4.4 3.6-5.1 g/dL
GLOBULIN,CALCULATED 2.6 2.1-3.7 g/dL
A/G RATIO 1.7 1.0-2.1
BILIRUBIN,TOTAL 1.2 0.2-1.2 mg/dL
ALKALINE PHOSPHATASE 68 40-115 U/L
AST 34 10-40 U/L
ALT 56 9-60 U/L
EGFR NON AFR AMERICAN 92 >=60 mL/min/1.73m2
EGFR AFRICAN AMERICAN 107 >=60 mL/min/1.73m2
CHOLESTEROL,TOTAL 171 125-200 mg/dL
HDL CHOLESTEROL 45 >=40 mg/dL
CHOLESTEROL/HDL RATIO 3.8 < = 5.0
LDL CHOL, CALCULATED 117 <130 mg/dL
Desirable range <100 mg/dL for patients with CHD or diabetes
and <70 mg/dL for diabetic patients with known heart
TRIGLYCERIDES 43 <150
NON HDL CHOLESTEROL 126
Target for non-HDL cholesterol is 30 mg/dL higher than
PROTEIN,TOTAL 7.0 6.2-8.3 g/dL
ALBUMIN 4.4 3.6-5.1 g/dL
GLOBULIN,CALCULATED 2.6 2.1-3.7 g/dL
A/G RATIO 1.7 1.0-2.1
BILIRUBIN,TOTAL 1.2 0.2-1.2 mg/dL
BILIRUBIN,DIRECT 0.3 < = 0.2 mg/dL
ALKALINE PHOSPHATASE 68 40-115 U/L
AST 34 10-40 U/L
ALT 56 9-60 U/L
BILIRUBIN,INDIRECT 0.9 0.2-1.2 mg/dL
WBC 4.4 3.8-10.8 Thous/mcL
RBC 5.03 4.20-5.80 Mill/mcL
HEMOGLOBIN 14.9 13.2-17.1 g/dL
HEMATOCRIT 43.3 38.5-50.0 %
MCV 86.2 80.0-100.0 fL
MCH 29.6 27.0-33.0 pg
MCHC 34.3 32.0-36.0 g/dL
RDW 14.0 11.0-15.0 %
PLATELET COUNT 151 140-400 Thous/mcL
MPV 10.0 7.5-11.5 fL
TOTAL NEUTROPHILS,% 39.4 38-80 %
TOTAL LYMPHOCYTES,% 52.7 15-49 %
MONOCYTES,% 7.0 0-13 %
EOSINOPHILS,% 0.6 0-8 %
BASOPHILS,% 0.3 0-2 %
NEUTROPHILS,ABSOLUTE 1734 1500-7800 Cells/mcL
LYMPHOCYTES,ABSOLUTE 2319 850-3900 Cells/mcL
MONOCYTES,ABSOLUTE 308 200-950 Cells/mcL
EOSINOPHILS,ABSOLUTE 26 15-500 Cells/mcL
BASOPHILS,ABSOLUTE 13 0-200 Cells/mcL
Analyte Result Value Ref. Range Units
HEPATITIS B SURFACE AB,QN /=10 mIU/mL
Patient does not have immunity to hepatitis B virus.
HEPATITIS B VIRUS DNA <20 Detected <20 IU/mL
HEPATITIS B VIRUS DNA <116 Detected <116 copies/mL
Analyte Result Value Ref. Range Units
RESULT Detected Not Detected
The patient should not have taken antimicrobials, proton
pump inhibitors or bismuth preparations within two weeks
prior to administering the Breath Tek(TM)-UBiT(TM), as these